Cutting Costs with Digital Signatures
Cutting Costs, accelerating processes in pharmaceutical, healthcare industries
Pharmaceutical and health care companies need to streamline processes and reduce costs in today’s tough economy. Manual signature processes are one are place they should be looking for savings. Relying on paper-based signatures is both costly and inefficient.
New digital signature technologies, combined with industry digital signature standards, can safely replace manual signatures for a significant cost savings.
Join Mollie Shields-Uehling, President & CEO of SAFE-BioPharma Association, and
Jack Martin, VP of Operations for TriCipher, in a live webcast on December 16 on moving your business to digital signatures.
Topics will include:
- Regulatory requirements, industry standards and digital signatures
- Streamlining submissions to FDA and others
- Potential cost savings
- Case study of digital signatures in a global pharmaceutical
Tuesday, December 16, 2008
2:00 pm ET | 11:00 am PT
Download a white paper on the costs of paper-based signatures.
